The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126729931 12672993 1 I 20160601 20160810 20160822 20160822 EXP FR-BAYER-2016-155788 BAYER 13.00 YR T M Y 0.00000 20160822 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126729931 12672993 1 PS CIFLOX CIPROFLOXACIN 1 Intravenous (not otherwise specified) UNK 19847 SOLUTION FOR INFUSION
126729931 12672993 2 SS CORTANCYL PREDNISONE 1 Oral 2 MG/KG, QD 2 MG/KG 0 2 MG/KG QD
126729931 12672993 3 SS LASILIX FUROSEMIDE 1 Oral 40 MG, QD 40 MG 0 40 MG QD
126729931 12672993 4 SS SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) 1MG/KG 0
126729931 12672993 5 SS SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) 35 MG, BID 0 35 MG BID
126729931 12672993 6 SS CEFOTAXIME CEFOTAXIME SODIUM 1 Intravenous (not otherwise specified) DAILY DOSE 33 MG/KG 0 33 MG
126729931 12672993 7 SS KETAMINE KETAMINE 1 Intravenous (not otherwise specified) UNK 0
126729931 12672993 8 SS CELOCURIN SUCCINYLCHOLINE CHLORIDE 1 Intravenous (not otherwise specified) UNK 0
126729931 12672993 9 SS NIMBEX CISATRACURIUM BESYLATE 1 Intravenous (not otherwise specified) UNK 0
126729931 12672993 10 SS TAVANIC LEVOFLOXACIN 1 Intravenous (not otherwise specified) UNK 0
126729931 12672993 11 SS SALBUTAMOL ALBUTEROL 1 Intravenous (not otherwise specified) 1.8 MCG/KG/MIN CONTINUOUS 0
126729931 12672993 12 SS SALBUTAMOL ALBUTEROL 1 Respiratory (inhalation) 5 MG, Q1HR 0 5 MG /hr
126729931 12672993 13 SS ATROVENT IPRATROPIUM BROMIDE 1 Respiratory (inhalation) 0.25 MG, Q3HR 0 .25 MG Q3H
126729931 12672993 14 SS LOXEN NICARDIPINE HYDROCHLORIDE 1 Oral UNK 0
126729931 12672993 15 SS MAGNESIUM SULFATE. MAGNESIUM SULFATE 1 Intravenous (not otherwise specified) 50 MG/KG, QD 0 50 MG/KG QD

Indications of drugs used

no results found

Outcome of event

Event ID CASEID OUTC COD
126729931 12672993 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126729931 12672993 Altered state of consciousness
126729931 12672993 Cerebrovascular accident
126729931 12672993 Cerebrovascular disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126729931 12672993 1 20160531 0
126729931 12672993 2 20160526 20160526 0
126729931 12672993 3 20160526 20160526 0
126729931 12672993 4 20160527 0
126729931 12672993 6 20160527 0
126729931 12672993 7 20160527 20160531 0
126729931 12672993 8 20160527 20160527 0
126729931 12672993 9 20160527 20160531 0
126729931 12672993 10 20160527 0
126729931 12672993 11 20160527 20160530 0
126729931 12672993 12 20160527 0
126729931 12672993 13 20160527 0
126729931 12672993 14 20160531 0
126729931 12672993 15 20160527 0